0001127602-22-008047.txt : 20220303 0001127602-22-008047.hdr.sgml : 20220303 20220303170441 ACCESSION NUMBER: 0001127602-22-008047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220301 FILED AS OF DATE: 20220303 DATE AS OF CHANGE: 20220303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jones Michael L CENTRAL INDEX KEY: 0001800060 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 22710078 MAIL ADDRESS: STREET 1: 4505 EMPEROR BLVD. STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-03-01 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001800060 Jones Michael L 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Exec. Director, Finance - PAO Common Stock 2022-03-01 4 M 0 2300 4.73 A 13498 D Common Stock 2022-03-01 4 S 0 2300 17.20 D 11198 D Emp. Stock Option (Right to Buy) 4.73 2022-03-01 4 M 0 2300 0 D 2013-03-01 2022-03-01 Common Stock 2300 0 D Michael L. Jones 2022-03-03